Early increase in apparent diffusion coefficient predicts favorable response to dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline glioma.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.